Celldex to Present at Upcoming Investor Conferences
Celldex (NASDAQ:CLDX) announced that management will participate in fireside chats at two upcoming healthcare investor conferences in November and December.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Celldex (NASDAQ:CLDX) announced that management will participate in fireside chats at two upcoming healthcare investor conferences in November and December. The Guggenheim 3rd Annual Healthcare Innovation Conference chat is scheduled for November 9, 2026, at 9:00am ET; the 9th Annual Evercore Healthcare Conference chat is on December 1, 2026, at 10:50am ET. Webcasts will be available on Celldex’s investor website, with replays available for 90 days following each event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HAMPTON, N.J., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming investor conferences:
- The Guggenheim 3rd Annual Healthcare Innovation Conference on November 9, 2026 at 9:00am ET.
- The 9th Annual Evercore Healthcare Conference on December 1, 2026 at 10:50am ET.
The webcasts of the Guggenheim and Evercore presentations will be available on the “Events and Presentations” page of the “Investors” section of the Celldex Website. Replays will be available for 90 days following the event.
About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com.
Company Contacts
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Elizabeth Higgins
Executive Director, Investor Relations & Corporate Communications
(857) 404-2088
ehiggins@celldex.com
